We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cannabis Safe and Effective for Elderly in Regular Use

By HospiMedica International staff writers
Posted on 06 Mar 2018
A new study shows that therapeutic use of cannabis is a safe and effective treatment for seniors, and is often a factor leading to the decreased use of other drugs, including opioids.

Researchers at Ben-Gurion University (BGU; Beer Sheva, Israel) and Tikun Olam (Tel Aviv, Israel) conducted a prospective study that included 2,736 patients 65 years and older who began cannabis treatment from January 2015 to October 2017 in a specialized cannabis clinic. More...
The most common indications for cannabis treatment were pain (66.6%) and cancer (60.8%). All patients were prescribed one or more of Tikun Olam's proprietary cannabis strains, with the main strains being Erez, (53.2%), Avidekel (33.4%), Alaska (25.7%), and Midnight (20.4%).

All patients filled an initial questionnaire, which assessed their characteristics, and the researchers then evaluated the treatment. The main outcomes were pain intensity, quality of life, and adverse events at six months. The results revealed that after six months of treatment, 93.7% reported an improvement in their condition, and reported pain levels were reduced from a median of 8 (on a scale of 0-10) to a median of 4. The most common adverse events were dizziness and dry mouth. After six months, 18.1% stopped using opioid analgesics or reduced their dose. The study was published on February 7, 2018, in the European Journal of Internal Medicine.

“There is a substantial growth in the use of medical cannabis in recent years, and with the aging of the population, medical cannabis is increasingly used by the elderly,” concluded senior author Victor Novack, PhD, of the BGU Cannabis Clinical Research Institute. “Our study finds that the therapeutic use of cannabis is safe and efficacious in the elderly population. Cannabis use may decrease the use of other prescription medicines, including opioids. Gathering more evidence-based data, including data from double-blind randomized-controlled trials, in this special population is imperative.”

“This pioneering clinical study on the use of cannabis in the geriatric population is the first step in finding safer, and less toxic medications for use in our elderly populations,” said Bernie Sucher, CEO of Tikun Olam. “This study is an unprecedented affirmation by the scientific community of the efficacy of medical marijuana in the elderly. These people are arguably the most medically vulnerable population, and already a large and growing proportion of the users of medical cannabis.”

Cannabis, also known as Marijuana, is composed of dried buds and leaves of varieties of the Cannabis sativa plant. The two most active components in marijuana are delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD). THC seems to cause the euphoria reported by users, and helps relieve pain and nausea and reduce inflammation. CBD can help treat seizures, reduce anxiety and paranoia, and counteract the THC high.

Related Links:
Ben-Gurion University
Tikun Olam


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.